Companies covered: IVERIC bio Inc. (NASDAQ:ISEE), Disc Medicine Inc. (NASDAQ:IRON), Nuvalent Inc. (NASDAQ:NUVL), Apellis Pharmaceuticals Inc. (NASDAQ:APLS), Amgen Inc. (NASDAQ:AMGN), Horizon Therapeutics PLC (NASDAQ:HZNP), Ipsen ADR (OTCMKTS:IPSEY), Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA), BioNTech SE (ADR) (NASDAQ:BNTX), Theseus Pharmaceuticals Inc. (NASDAQ:THRX), Mersana Therapeutics Inc. (NASDAQ:MRSN), Argenx SE (ADR) (NASDAQ:ARGX), Genmab A/S - ADR (NASDAQ:GMAB), Janux Therapeutics Inc. (NASDAQ:JANX)), Johnson & Johnson (NYSE:JNJ), AbbVie Inc. (NYSE:ABBV), Seagen Inc. (NASDAQ:SGEN), Roche Holdings Ltd. (ADR) (OTCMKTS:RHHBY), Chinook Therapeutics Inc. (NASDAQ:KDNY), Pfizer, Inc. (NYSE:PFE), Lisata Therapeutics Inc. (NASDAQ:LSTA), Omeros Corporation (NASDAQ:OMER), Cidara Therapeutics Inc. (NASDAQ:CDTX), Gilead Sciences, Inc. (NASDAQ:GILD), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), United Therapeutics Corporation (NASDAQ:UTHR), Astria Therapeutics Inc. (NASDAQ:ATXS), Biomea Fusion Inc. (NASDAQ:BMEA), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Merck & Company, Inc. (NYSE:MRK), Abivax (OTCMKTS:AAVXF), EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT), GeoVax Labs, Inc. (NASDAQ:GOVX), Organovo Holdings, Inc. (NASDAQ:ONVO), Telesis Bio Inc. (NASDAQ:TBIO), Codex DNA, Inc. (NASDAQ:DNAY), TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)
